Disclosed herein is a foamable composition and a foam, its use, and process for its preparation. The foamable composition comprises: short-chain alcohol(s); a surfactant; a sensation modifying agent; water; and optionally an additive and/or second acceptable surfactant. The composition provides physical stability, an improved foam quality, consumer/sensory benefits and is useful for topical application.

Disclosed is a package that comprises a plurality of personal cleansing cloths each impregnated with an aqueous cleansing composition that includes a skin cooling agent, a fragrance, a skin conditioning agent, and one or more botanical extracts. The botanical extract may comprise one or more of coffee seed extract, Punica Granatum extract, Croton Lechleri extract, Panax extract, and Crataegus Monogyna extract. In use, a personal cleansing method may comprise removing a personal cleansing cloth from the package and self-cleansing using the personal cleansing cloth.

Proposed are preparations, comprising special amides and menthol or menthol compounds or aromatic substances, characterized in that they have improved flavor and scent properties, and also that they allow the production of preparations, particularly emulsions with improved shelf life.

A frozen therapeutic dose includes an amniotic material and is configured into a pack for easy administering of the dose to a treatment location. A frozen therapeutic dose may contain a concentration of live amniotic stem cells. A frozen therapeutic dose may be provided in a form, such as a multi-pack form, to enable a person to administer a dose to a treatment location without the need of traveling to a doctor's office or clinic. A frozen therapeutic dose package may be kept in a conventional freezer at 20 C., for example, for extended periods of time and a person may remove the package as needed for treatment. A frozen dose package or pack may contain a secondary material configured to mix with the frozen therapeutic dose. A secondary material may be configured within a single dose compartment with the frozen dose or within a separate compartment.

The invention relates to new types of modulators of the cold menthol receptor TRPM8, to methods of modulating the TRPM8 receptor using these modulators; and in particular the use of the modulators for inducing a sensation of coldness; and also the articles and compositions produced using these modulators.

A skin engaging shaving aid member suitable for use in a shaving device, said skin engaging shaving aid member comprising a thermally resilient sensate such as N-substituted menthanecarboxamide.

Disclosed are TRPM8 modulators as defined by formula (I) for achieving a cooling effect on skin and mucousa.

Disclosed is a personal care composition comprising cooling active and copolymer comprising acrylamidopropyltrimonium chloride, wherein the weight ratio of the amount of the cooling active to the amount of the copolymer is in the range from 1:5 to 100:1. The copolymer improves deposition of the cooling active during topical application of the product to skin.

The invention relates to an alcohol-free cosmetic or therapeutic foam carrier comprising water, a hydrophobic organic carrier, a foam adjuvant agent, a surface-active agent and a gelling agent. The cosmetic or therapeutic foam carrier does not contain aliphatic alcohols, making it non-irritating and non-drying. The alcohol-free foam carrier is suitable for inclusion of both water-soluble and oil soluble therapeutic and cosmetic agents.

Disclosed are TRPM8 modulators as defined by formula (I) for achieving a cooling effect on skin and mucousa.